Teva Pharmaceutical Industries Limited (TEVA)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
10.52-0.06 (-0.57%)
At close: 4:00PM EST
10.54 +0.02 (0.19%)
After hours: 6:30PM EST
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 11.49B |
| Enterprise value 3 | 36.99B |
| Trailing P/E | N/A |
| Forward P/E 1 | 3.84 |
| PEG ratio (5-yr expected) 1 | 0.84 |
| Price/sales (ttm) | 0.69 |
| Price/book (mrq) | 1.15 |
| Enterprise value/revenue 3 | 2.22 |
| Enterprise value/EBITDA 6 | 8.02 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.45 |
| 52-week change 3 | N/A |
| S&P500 52-week change 3 | N/A |
| 52-week high 3 | 13.30 |
| 52-week low 3 | 6.25 |
| 50-day moving average 3 | 11.68 |
| 200-day moving average 3 | 10.13 |
Share statistics
| Avg vol (3-month) 3 | 9.77M |
| Avg vol (10-day) 3 | 10.07M |
| Shares outstanding 5 | 1.1B |
| Float | 1.09B |
| % held by insiders 1 | 1.02% |
| % held by institutions 1 | 51.78% |
| Shares short (11 Feb 2021) 4 | 34.47M |
| Short ratio (11 Feb 2021) 4 | 3.26 |
| Short % of float (11 Feb 2021) 4 | N/A |
| Short % of shares outstanding (11 Feb 2021) 4 | 3.14% |
| Shares short (prior month 14 Jan 2021) 4 | 29.75M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 11 Dec 2017 |
| Ex-dividend date 4 | 26 Nov 2017 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 30 Jun 2004 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2020 |
| Most-recent quarter (mrq) | 30 Dec 2020 |
Profitability
| Profit margin | -23.95% |
| Operating margin (ttm) | 18.34% |
Management effectiveness
| Return on assets (ttm) | 3.53% |
| Return on equity (ttm) | -31.38% |
Income statement
| Revenue (ttm) | 16.66B |
| Revenue per share (ttm) | 15.21 |
| Quarterly revenue growth (yoy) | -0.30% |
| Gross profit (ttm) | 7.73B |
| EBITDA | 4.61B |
| Net income avi to common (ttm) | -3.99B |
| Diluted EPS (ttm) | -3.64 |
| Quarterly earnings growth (yoy) | 37.60% |
Balance sheet
| Total cash (mrq) | 2.18B |
| Total cash per share (mrq) | 1.99 |
| Total debt (mrq) | 26.54B |
| Total debt/equity (mrq) | 239.90 |
| Current ratio (mrq) | 0.99 |
| Book value per share (mrq) | 9.14 |
Cash flow statement
| Operating cash flow (ttm) | 1.22B |
| Levered free cash flow (ttm) | 1.73B |
© 2021 Verizon Media. All rights reserved.
